Vulvovaginitis due to Candida glabrata.: An emerging problem

被引:49
作者
Sobel, JD [1 ]
机构
[1] Wayne State Univ, Harper Hosp, Sch Med, DMC,Detroit Med Ctr,Dept Internal Med, Detroit, MI 48201 USA
关键词
Candida glabrata; vaginitis; vulvovaginitis;
D O I
10.1111/j.1439-0507.1998.tb00594.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A review is presented of the emerging problem of resistant and chronic vaginitis due to Candida glabrata. Although accurate numbers are lacking, several investigators report encountering increased numbers of women with vaginitis due to C. glabrata. Possible reasons for this apparent increase are discussed. Risk factors and clinical manifestations of symptomatic C. glabrata vaginitis differ from those of C, albicans, C. glabrata being less susceptible to fungistatic azole agents is more difficult to eradicate. Successful management of chronic C. glabrata vaginitis constitutes a major challenge with currently available therapeutic agents.
引用
收藏
页码:18 / 22
页数:5
相关论文
共 17 条
[1]  
Cauwenbergh G., 1990, CURR PROB OBST GYN F, V8, P241
[2]   Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus [J].
DeBernardis, F ;
Chiani, P ;
Ciccozzi, M ;
Pellegrini, G ;
Ceddia, T ;
DOffizzi, G ;
Quinti, I ;
Sullivan, PA ;
Cassone, A .
INFECTION AND IMMUNITY, 1996, 64 (02) :466-471
[3]   DEVELOPMENT OF RESISTANCE IN CANDIDA ISOLATES FROM PATIENTS RECEIVING PROLONGED ANTIFUNGAL THERAPY [J].
FANHAVARD, P ;
CAPANO, D ;
SMITH, SM ;
MANGIA, A ;
ENG, RHK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2302-2305
[4]  
FIDEL PL, 1996, J INFECT DIS, V173, P125
[5]  
GEIGER AM, 1995, GENITOURIN MED, V71, P301
[6]  
Kwon-Chung J.K., 1992, MED MYCOL
[7]  
Lynch ME, 1996, J MED VET MYCOL, V34, P337
[8]  
LYNCH ME, 1994, J MED VET MYCOL, V32, P267
[9]  
REDONDOLOPEZ V, 1990, OBSTET GYNECOL, V76, P651
[10]   Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection - A randomized, double-blind, placebo-controlled trial [J].
Schuman, P ;
Capps, L ;
Peng, G ;
Vazquez, J ;
ElSadr, W ;
Goldman, AI ;
Alston, B ;
Besch, CL ;
Vaughn, A ;
Thompson, MA ;
Cobb, MN ;
Kerkering, T ;
Sobel, JD .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (09) :689-+